Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing
Despite prolonged and intensive application, combined antiretroviral therapy cannot eradicate human immunodeficiency virus (HIV)-1 because it is harbored as a latent infection, surviving for long periods of time. Alternative approaches are required to overcome the limitations of current therapy. We...
Saved in:
Main Authors: | Kazuo Suzuki (Author), Shinichiro Hattori (Author), Katherine Marks (Author), Chantelle Ahlenstiel (Author), Yosuke Maeda (Author), Takaomi Ishida (Author), Michelle Millington (Author), Maureen Boyd (Author), Geoff Symonds (Author), David A Cooper (Author), Seiji Okada (Author), Anthony D Kelleher (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing
by: Chantelle Ahlenstiel, et al.
Published: (2015) -
Endoglin (CD105) Silencing Mediated by shRNA Under the Control of Endothelin-1 Promoter for Targeted Gene Therapy of Melanoma
by: Natasa Tesic, et al.
Published: (2015) -
Non-targeting control for MISSION shRNA library silences SNRPD3 leading to cell death or permanent growth arrest
by: Maria Czarnek, et al.
Published: (2021) -
Promoter Targeting RNAs: Unexpected Contributors to the Control of HIV-1 Transcription
by: Kazuo Suzuki, et al.
Published: (2015) -
Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer
by: Shan-Shan Hong, et al.
Published: (2018)